Mark R. Willig
Vorstandsvorsitzender bei Key Proteo Inc
Profil
Mark R.
Willig currently works at Key Proteo, Inc., as President & Chief Executive Officer.
Mr. Willig also formerly worked at Specialty Laboratories, Inc., as Executive Vice President-Sales & Marketing, CardioDx, Inc., as Senior Vice President-Sales, Rosetta Genomics Ltd., as Chief Commercial Officer, Thermo Fisher Scientific, Inc., as Vice President-Global Sales, Abbott Diagnostics, Inc., as Manager-Integrated Health System, Myriad Genetic Laboratories, Inc., as Vice President-Sales, Agendia, Inc., as Executive Vice President-Global Sales, and Exiqon, Inc., as Chief Commercial Officer.
Mr. Willig received his undergraduate degree from the University of Missouri.
Aktive Positionen von Mark R. Willig
| Unternehmen | Position | Beginn |
|---|---|---|
Key Proteo Inc
 Key Proteo Inc Medical/Nursing ServicesHealth Services Key Proteo Inc specializes in novel peptide screening for newborn babies and is specialized in multiplex analysis for extremely low abundance proteins from a few drops of blood (DBS). The company is located in the US. The American company's mission is to provide preemptive treatment for genetic diseases before they are clinically manifested by expanding and improving newborn screening programs. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Mark R. Willig
| Unternehmen | Position | Ende |
|---|---|---|
| Exiqon, Inc. | Corporate Officer/Principal | - |
Specialty Laboratories, Inc.
 Specialty Laboratories, Inc. Medical/Nursing ServicesHealth Services Specialty Laboratories, Inc. provides clinical reference laboratory services. It focuses on cutting-edge research and development of existing diagnostic tests to produce assays. The company was founded in 1975 and is located in Valencia, CA. | Vertrieb & Marketing | 01.06.2005 |
| ROSETTA GENOMICS LTD. | Corporate Officer/Principal | - |
Agendia, Inc.
 Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Vertrieb & Marketing | - |
Abbott Diagnostics, Inc.
 Abbott Diagnostics, Inc. Medical SpecialtiesHealth Technology Abbott Diagnostics, Inc. develops, manufactures and sells medical diagnostic instrument, test and automation products. The company is headquartered in Santa Clara, CA. | Corporate Officer/Principal | - |
Ausbildung von Mark R. Willig
| University of Missouri | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| THERMO FISHER SCIENTIFIC | Health Technology |
| ROSETTA GENOMICS LTD. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Specialty Laboratories, Inc.
Specialty Laboratories, Inc. Medical/Nursing ServicesHealth Services Specialty Laboratories, Inc. provides clinical reference laboratory services. It focuses on cutting-edge research and development of existing diagnostic tests to produce assays. The company was founded in 1975 and is located in Valencia, CA. | Health Services |
CardioDx, Inc.
 CardioDx, Inc. Medical/Nursing ServicesHealth Services CardioDx, Inc. operates as a cardiovascular genomic diagnostics firm. It develops proprietary tests that improve treatment decisions and patient outcomes on coronary artery disease, cardiac arrhythmia, and heart failure. The company was founded by David L. Levison and Christopher R. Burrow in 2004 and is headquartered in Redwood, CA. | Health Services |
Myriad Genetic Laboratories, Inc.
 Myriad Genetic Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Myriad Genetic Laboratories, Inc. provides cancer predisposition testing services. It operates as a biopharmaceutical company that focuses on developing therapeutic and predictive medicine products. The company was founded on October 11, 1995 and is headquartered in Salt Lake City, UT. | Commercial Services |
Abbott Diagnostics, Inc.
Abbott Diagnostics, Inc. Medical SpecialtiesHealth Technology Abbott Diagnostics, Inc. develops, manufactures and sells medical diagnostic instrument, test and automation products. The company is headquartered in Santa Clara, CA. | Health Technology |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Health Technology |
| Exiqon, Inc. | |
Key Proteo Inc
Key Proteo Inc Medical/Nursing ServicesHealth Services Key Proteo Inc specializes in novel peptide screening for newborn babies and is specialized in multiplex analysis for extremely low abundance proteins from a few drops of blood (DBS). The company is located in the US. The American company's mission is to provide preemptive treatment for genetic diseases before they are clinically manifested by expanding and improving newborn screening programs. | Health Services |
